NCT05107271View on ClinicalTrials.gov

Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

December 15, 2022

Study Completion Date

March 15, 2024

Conditions
COVID-19Chronic Liver FailureCirrhosis, LiverPortal HypertensionLiver Transplant Disorder
Interventions
DIAGNOSTIC_TEST

COVID-19 serosurvey

COVID-19 related antibody testing to assess immunogenicity of COVID-19 vaccines or post natural infection acquired immunity

Trial Locations (1)

160012

PGIMER, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT05107271 - Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease | Biotech Hunter | Biotech Hunter